Pages that link to "Q39916520"
Jump to navigation
Jump to search
The following pages link to Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model (Q39916520):
Displaying 26 items.
- An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells (Q28547142) (← links)
- IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells (Q28551043) (← links)
- Indoleamine 2,3-dioxygenase promotes peritoneal metastasis of ovarian cancer by inducing an immunosuppressive environment (Q35051622) (← links)
- Immunological and nonimmunological effects of indoleamine 2,3-dioxygenase on breast tumor growth and spontaneous metastasis formation (Q35986384) (← links)
- Cancer-associated fibroblast suppresses killing activity of natural killer cells through downregulation of poliovirus receptor (PVR/CD155), a ligand of activating NK receptor (Q37252683) (← links)
- The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer (Q37329058) (← links)
- Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases (Q37522460) (← links)
- Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses (Q37524719) (← links)
- Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer (Q37798692) (← links)
- The immunoregulatory mechanisms of carcinoma for its survival and development (Q37831426) (← links)
- Tumor immune surveillance and ovarian cancer: lessons on immune mediated tumor rejection or tolerance (Q37836612) (← links)
- Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment (Q38363548) (← links)
- Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO. (Q38979523) (← links)
- Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma (Q39814919) (← links)
- EWS-FLI1 impairs aryl hydrocarbon receptor activation by blocking tryptophan breakdown via the kynurenine pathway (Q42350421) (← links)
- Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy (Q43115659) (← links)
- IDO and outcomes in ovarian cancer (Q43263135) (← links)
- Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status (Q48182026) (← links)
- Effects of indoleamine 2,3-dioxygenase inhibitor in non-Hodgkin lymphoma model mice. (Q53394735) (← links)
- Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics. (Q54190983) (← links)
- Evaluation of the toxicity of iron-ion irradiation in murine bone marrow dendritic cells via increasing the expression of indoleamine 2,3-dioxygenase 1. (Q64985685) (← links)
- Genome-wide identification of possible methylation markers chemosensitive to targeted regimens in colorectal cancers (Q84785186) (← links)
- Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors (Q89621123) (← links)
- Immunometabolic Network Interactions of the Kynurenine Pathway in Cutaneous Malignant Melanoma (Q89966989) (← links)
- miR-448 targets IDO1 and regulates CD8 T cell response in human colon cancer (Q92480951) (← links)
- Immune disorder in endometrial cancer: Immunosuppressive microenvironment, mechanisms of immune evasion and immunotherapy (Q98386332) (← links)